BioPharma Dive ١١ فبراير ٢٠٢٦ Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug
BioPharma Dive ١٠ فبراير ٢٠٢٦ Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
BioPharma Dive ٩ فبراير ٢٠٢٦ Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals
BioPharma Dive ٦ فبراير ٢٠٢٦ White House’s online service for drug sales debuts with limited impact on prices
BioPharma Dive ٥ فبراير ٢٠٢٦ Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game